Hey Emmitt, I don't think anyone answered your question,

New Post Public Reply Private Reply Replies (1) Message Board
Respert24 Emmitt #112881
769
Hey Emmitt,

I don't think anyone answered your question, and as our board's number 2 science guy behind TonyCorvette, I figured I'd give you a quick answer.

You seem to be mashing up how a drug is delivered with whether or not the FDA allows it to be a prescription medicine or not. They're only related in that many drugs delivered in pills are currently offered over the counter. But there are also transdermal patches, nasal sprays, and syrups offered over the counter. There are also drugs offered without prescription that have some decent potential for abuse, like the ephedrine/pseudoephedrine in allergy meds that get used to make meth.

Eventually, a drug like LL should become easier to get and much, much cheaper. But while that would be great for any of us who could benefit from having it with a quick trip to CVS and no prescription, the reality is that we'd make no money from our investment if LL wasn't first a prescription drug that was offered through our country's current physician-insurance framework.

It takes hundreds of millions, if not billions, along with many years of research and development efforts to get a drug to market and the best way to make that money back, and make a bunch of money to fund future indications/products, is to sell it at $8,000/treatment (or whatever) through insurance. The patient still typically pays only a reasonable amount but insurance or a government covers the rest. Cytodyn makes a bunch and smartly reinvests it, the stock goes through the roof, we all make f-you money, and then as patent life extensions finally wear thin it'll be available to the world in an easier and cheaper way.

But along the way we'll have LL Extended Release, LL Respimat Inhaler, LL syrup, LL for Lefties, LL+CBD Gummies, and a variety of other versions that allow us to extend our exclusivity.

There also remains a good reason to first bring a drug through the FDA's process and our current insurance model of healthcare. The FDA approval is both a rubber stamp that it's "safe" and also a way to ensure things are manufactured, marketed, and taken in a safe and trackable way. You won't have some shady company based in India (a huge generics market) making knockoff LL that has no active ingredient or contains filler compounds that are carcinogenic because they aren't regulated. We get regulation surrounding our drug (all drugs) and then as time goes one many of them can transition to over the counter when they're deemed safe and capable of being left in the hands of our unwashed masses. You have to be careful so dumbasses like justa on the other board don't accidentally overdose or kill themselves trying to make meth out of it.

In the end it still costs a good bit and requires highly technical capabilities to make LL, so I don't know if we'll ever see it priced and available like aspirin. But it should absolutely become less expensive and easier to get in the future. After we've all sprained our necks diving into our gold coins like Scrooge McDuck. Hmm, I wonder if LL can help a sprained neck muscle...

I hope that helps.

Respert

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Orthopedic Expert Highlighting Midwest Pain Access Gaps

Updated Category News Views 5

Over in the vast sprawl of rolling plains and prairie winds, folks in the Upper Midwest are grappling with an ironic reality. As technological advancements blaze trails, people suffering from vertebrogenic pain are finding themselves up against a wall of limited access to specialized care. We’ve got Dr. James T. Brunz, the man of the hour, one of only about 15 Intracept...

Continue Reading
CSS Revamps Identity, Emphasizing Senior Living Tech

Updated Category News Views 5

CSS Takes a Bold Step with a Fresh Brand Identity Every now and then, you see a company shake off the old coat and put on a polished new one. That's what CSS is doing with its updated brand, staking its claim as a heavyweight tech player in the senior living sector. No small feat, given the challenges stacked against these aging communities—tasked with keeping...

Continue Reading
Lumicell Expands LumiSystem in Breast Cancer Surgery

Updated Category News Views 7

Innovation in Breast Cancer Surgery: A Real-World Game Changer? You’ve got your flashlight guiding a scared child through the dark, and in the healthcare world, Lumicell is promising to do just that for surgeons navigating the tricky maze of breast cancer surgery. Their LumiSystem is making waves in breast-conserving surgery—new kid on the block with a real chance at...

Continue Reading
BMAP Expands: Bridging Borders in Legal Advocacy

Updated Category News Views 5

Breaking Down BMAP's Unique Approach Just when you thought you've seen it all, along comes LMU Loyola Law School swinging the doors wide open with their Binational Migrant Advocacy Project, or as we’re affectionately calling it, BMAP. It's a mouthful, sure, but ain't it something? This project isn't just another feather in academia's cap—it's a relentless counterpunch...

Continue Reading
FC2 Condom Educates NYC on Health and Wellness

Updated Category News Views 9

Union Square Becomes a Hub of Interactivity The heart of NYC pulsed with purpose as FC2 Female Condom set up shop in Union Square, using the iconic location as a stage for a different kind of celebration. Clear Future, the manufacturer behind FC2, marked Global Female Condom Day with an event unlike any other. It wasn't just about the product—it was a call to educate...

Continue Reading
Citrine Finalizes Sale of Illinois Senior Living Asset

Updated Category News Views 7

Citrine's Strategic Exit from River Glen Every now and then, you see a company pull off something that makes you nod and say, "That was smart." Citrine Investment Group's sale of River Glen of St. Charles fits that bill. For those keeping tabs, this wasn't some quick flip—Citrine worked on the rock for a good while before cashing in. They secured River Glen back in...

Continue Reading
Paula's Choice Elevates Skincare Game with New Campaign

Updated Category News Views 6

Strategy Meets Skincare: Paula's Choice in the Spotlight Catch this: Paula's Choice just dropped a moisturizer, but it ain't just lotion. No, the Pro-Collagen Peptide Plumping Intensive Moisturizer is here with a punch. And they've got Hannah Waddingham, of 'Ted Lasso' fame, fronting a campaign that screams confidence. Now, that's a way to announce your move at the...

Continue Reading
Feeding Families Foundation Gains $121,500 for NYC Push

Updated Category News Views 5

Holy smokes, here comes some good news in the nonprofit corners! Feeding Families Foundation just got a hefty $121,500 boost from the Association of Contracting Plumbers of the City of New York Inc. This ain't just some pocket change; it's a full-fledged lifeline that helps them keep on delivering meals to parents who are practically living at their kid’s hospital...

Continue Reading
Perk's U.S. Expansion: A Bold Move in Spend Control

Updated Category News Views 7

Perk Aims for U.S. Growth: Will It Pay Off? Amidst the cacophony of market chatter, Perk's announcement to bring its spend platform stateside is echoing louder than usual. This move is not just another step in its expansion but rather a leap considering the competition and market needs. In Europe, where they've already captured a chunk of the market with their Travel and...

Continue Reading
TGI Fridays Unveils New 3 For All Menu Options

Updated Category News Views 8

Hedging Bets on New Dining Strategies Oh, the restaurant battlefield—where one day you're the toast of the town, and the next, you're hustling to keep those seats filled. TGI Fridays, a name as synonymous with casual eats as long as I’ve been in this game, is rolling the dice with a new offering dubbed '3 For All.' Doesn't sound like your average meal deal either....

Continue Reading

Top 5 Most Recently Viewed Articles

Discover Planful's AI Analyst Assistant for Finance Teams

Updated Category News Views 316

Planful Unveils Innovative Analyst Assistant to Enhance Finance An AI Assistant That Delivers Instant Insights and Frees Teams In an exciting development for finance professionals, Planful Inc., a leader in financial performance management cloud software, has unveiled its new AI Analyst Assistant. This innovative tool is designed specifically for finance teams, enhancing...

Continue Reading
14700 TP, LLC Announces Major Acquisition of Ten Pines

Updated Category News Views 193

14700 TP, LLC's Strategic Move with Ten Pines Acquisition 14700 TP, LLC is making headlines with the successful acquisition of Ten Pines at Summerwood, a luxury residential community located in an ideal area. This strategic investment, valued at $31.2 million, showcases the company's commitment to expanding its real estate portfolio with high-quality properties designed...

Continue Reading
Mission Rock Residential Takes Charge of Reno Apartment Living

Updated Category News Views 264

Mission Rock Residential Hired for Reno Apartment Community Mission Rock Residential, a recognized leader in property management, has stepped into an exciting role by taking over the management of the Village of the Pines, a beautiful 272-unit garden-style apartment community. The owners have confidently entrusted this significant contract to Mission Rock Residential,...

Continue Reading
Kojamo plc Reports Growth in Revenue and Occupancy Rates

Updated Category News Views 115

Kojamo plc's Financial Overview for 2025 Kojamo plc has released its financial statements highlighting a positive performance in 2025. The company experienced a growth in total revenue and net rental income, underscoring a robust real estate management strategy even against the backdrop of property sales. Summary of Financial Performance In 2025, Kojamo achieved...

Continue Reading
Silver Arch Capital Partners Completes $14.5M Bridge Loan Deal

Updated Category News Views 250

Silver Arch Capital Partners Secures Major Bridge Loan Silver Arch Capital Partners has announced the successful closing of a $14.5 million bridge loan aimed at financing eight unsold condominium units along with 74 parking spaces. This loan, featuring a loan-to-value (LTV) ratio of 65%, comes with a term of one year including extension options, reflecting the company's...

Continue Reading